{
  "catalogId": "9a164f5b-a1d9-437c-8604-059300be90cc",
  "name": "AMVUTTRA 25 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "176 25 37761 99",
  "treatmentDescriptions": "Amvuttra is indicated for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.",
  "termsOfIssue": "Prescription required",
  "form": "solution for injection",
  "route": "s.c",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "VUTRISIRAN AS SODIUM/ML",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "N07XX18",
      "name": "VUTRISIRAN"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "AMVUTTRA 25MG/0.5ML 1 PFS",
      "manufacturer": {
        "name": "מדיסון",
        "countryOfOrigin": "IL"
      },
      "strength": [
        {
          "value": 25.0,
          "unit": "mg"
        }
      ],
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "SYRINGE PREFILLED  GLASS TYPE I",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "9464",
        "yarpa": "30586"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 313577.8335,
        "retailMargin": 10.0,
        "maxRetailPrice": 344935.6168,
        "maxPriceWithVAT": 407024.0098
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:53.189427"
  }
}